LEADER 02220oam 2200649 450 001 9910704186903321 005 20151118153433.0 035 $a(CKB)5470000002437792 035 $a(OCoLC)883337241 035 $a(EXLCZ)995470000002437792 100 $a20140710d1937 ua 0 101 0 $aeng 135 $aurbn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aGeologic factors in the interpretation of fluorspar reserves in the Illinois-Kentucky field /$fby L.W. Currier 210 1$a[Washington, D.C.] :$cUnited States Department of the Interior, Geological Survey,$d1937. 210 2$aWashington :$cUnited States Government Printing Office. 215 $a1 online resource (ii, 5-14 pages, 1 page of plates) $cillustrations 225 1 $aBulletin / United States Department of the Interior, Geological Survey ;$v886-B 225 1 $aContributions to economic geology ;$v1937 300 $aTitle from title screen (viewed July 9, 2014). 517 3 $aFluorspar reserves in the Illinois-Kentucky field 606 $aFluorspar$zIllinois 606 $aFluorspar$zKentucky 606 $aGeology$zIllinois 606 $aGeology$zKentucky 606 $aMines and mineral resources$zIllinois 606 $aMines and mineral resources$zKentucky 606 $aFluorspar$2fast 606 $aGeology$2fast 606 $aMines and mineral resources$2fast 607 $aIllinois$2fast 607 $aKentucky$2fast 615 0$aFluorspar 615 0$aFluorspar 615 0$aGeology 615 0$aGeology 615 0$aMines and mineral resources 615 0$aMines and mineral resources 615 7$aFluorspar. 615 7$aGeology. 615 7$aMines and mineral resources. 700 $aCurrier$b L. W$g(Louis Wade),$f1890-1970,$01387196 712 02$aGeological Survey (U.S.), 801 0$bCOP 801 1$bCOP 801 2$bOCLCO 801 2$bOCLCA 801 2$bOCLCF 801 2$bOCLCO 801 2$bGPO 906 $aBOOK 912 $a9910704186903321 996 $aGeologic factors in the interpretation of fluorspar reserves in the Illinois-Kentucky field$93533185 997 $aUNINA LEADER 04512nam 2200613Ia 450 001 9910785765703321 005 20230801224332.0 010 $a0-309-21969-8 010 $a1-283-63646-8 010 $a0-309-21967-1 035 $a(CKB)2670000000241221 035 $a(EBL)3378993 035 $a(SSID)ssj0000665823 035 $a(PQKBManifestationID)11396036 035 $a(PQKBTitleCode)TC0000665823 035 $a(PQKBWorkID)10647452 035 $a(PQKB)10630008 035 $a(MiAaPQ)EBC3378993 035 $a(Au-PeEL)EBL3378993 035 $a(CaPaEBR)ebr10594218 035 $a(CaONFJC)MIL394892 035 $a(OCoLC)923289220 035 $a(EXLCZ)992670000000241221 100 $a20120723d2012 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aFacing the reality of drug-resistant tuberculosis$b[electronic resource] $echallenges and potential solutions in India : summary of a joint workshop /$fby the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research ; Steve Olson ... [et al.], rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$d2012 215 $a1 online resource (187 p.) 300 $aDescription based upon print version of record. 311 $a0-309-21966-3 320 $aIncludes bibliographical references. 327 $a""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Drug-Resistant TB in India""; ""3 The Global Burden of Drug-Resistant TB""; ""4 Preventing Transmission of Drug-Resistant TB""; ""5 Detecting Drug Resistance and Strengthening Laboratory Capacity""; ""6 Addressing TB and Drug-Resistant TB in Vulnerable Populations""; ""7 Combating Drug-Resistant TB Through Public Private Collaboration and Innovative Approaches""; ""8 Confronting Challenges to the Supply Chain for Second Line Drugs""; ""9 Creating a Blueprint for Action"" 327 $a""References""""Appendix A: Workshop Agenda""; ""Appendix B: Summary of a Joint Meeting of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Indian Biomedical Research Agencies, Held April 20-21, 2011, New Delhi, India""; ""Appendix C: Participant Biographies"" 330 $a"An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were developed in the 1950s and are effective against a majority of TB cases, resistance to these antibiotics has emerged over the years, resulting in the growing spread of multidrug-resistant (MDR) TB. Due to challenges in timely and accurate diagnosis of drug-resistant TB, length and tolerability of treatment regimens, and expense of second-line anti-TB drugs, effectively controlling the disease requires complex public health interventions. The IOM Forum on Drug Discovery, Development, and Translation held three international workshops to gather information from local experts around the world on the threat of drug resistant TB and how the challenges it presents can be met. Workshops were held in South Africa and Russia in 2010. The third workshop was held April 18-19, 2011, in New Delhi, India, in collaboration with the Indian National Science Academy and the Indian Council of Medical Research. The aim of the workshop was to highlight key challenges to controlling the spread of drug-resistant strains of TB in India and to discuss strategies for advancing and integrating local and international efforts to prevent and treat drug-resistant TB. This document summarizes the workshop."--Publisher's description. 606 $aMultidrug-resistant tuberculosis 606 $aAntitubercular agents 615 0$aMultidrug-resistant tuberculosis. 615 0$aAntitubercular agents. 676 $a616.995 701 $aOlson$b Steve$f1956-$0488724 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 712 02$aIndian National Science Academy. 712 02$aIndian Council of Medical Research. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910785765703321 996 $aFacing the reality of drug-resistant tuberculosis$93726300 997 $aUNINA